Gendelman H, Olson K, Namminga K, Lu Y, Mostafa M, Obaro H, Santamaria P, Mosley RL. A multiyear follow-on study examining safety, immunity, and clinical outcomes for sargramostim therapy in Parkinson’s disease.. [DOI: 10.21203/rs.3.rs-1957469/v1][Reference Citation Analysis]